Drug General Information
Drug ID	D0M7LC
Former ID	DNC013420
Drug Name	4-(6-hydroxynaphthalen-2-yl)benzene-1,3-diol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528496]
Structure		Download 2D MOL 3D MOL
Formula	C16H12O3
Canonical SMILES	C1=CC2=C(C=CC(=C2)O)C=C1C3=C(C=C(C=C3)O)O
InChI	1S/C16H12O3/c17-13-4-3-10-7-12(2-1-11(10)8-13)15-6-5-14(18)9-16(15)19/h1-9,17-19H
InChIKey	BXZJBSHLEZAMOP-UHFFFAOYSA-N
PubChem Compound ID	16215105
Target and Pathway
Target(s)	Tyrosine oxidase	Target Info	Inhibitor	[528496]
BioCyc Pathway	(S)-reticuline biosynthesis
	Eumelanin biosynthesis
	L-dopachrome biosynthesis
KEGG Pathway	Tyrosine metabolism
	Riboflavin metabolism
	Metabolic pathways
	Melanogenesis
PathWhiz Pathway	Riboflavin Metabolism
	Tyrosine Metabolism
WikiPathways	Dopamine metabolism
References
Ref 528496	Bioorg Med Chem Lett. 2007 Jan 15;17(2):461-4. Epub 2006 Oct 12.Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase.
Ref 528496	Bioorg Med Chem Lett. 2007 Jan 15;17(2):461-4. Epub 2006 Oct 12.Syntheses of hydroxy substituted 2-phenyl-naphthalenes as inhibitors of tyrosinase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.